1032279-33-6

Basic information

• Product Name: 7-methoxy-2,3-dihydro-1H-inden-1-amine
• Synonyms: 7-methoxy-2,3-dihydro-1H-inden-1-amine;2,3-dihydro-7-Methoxy-1H-inden-1-aMine
• CAS NO: 1032279-33-6
• Molecular Formula: C10H13NO
• Molecular Weight: 163.21632
• Mol File: 1032279-33-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 7-methoxy-2,3-dihydro-1H-inden-1-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-methoxy-2,3-dihydro-1H-inden-1-amine(1032279-33-6)
• EPA Substance Registry System: 7-methoxy-2,3-dihydro-1H-inden-1-amine(1032279-33-6)

Safety Data

• Hazardous Substances Data: 1032279-33-6(Hazardous Substances Data)

Usage

Uses

Due to the limited information available on 7-methoxy-2,3-dihydro-1H-inden-1-amine, its specific applications are not well-documented. However, given its classification as an aromatic homomonocyclic compound, it may potentially be used in various chemical and pharmaceutical industries for the following purposes:
Used in Chemical Synthesis:
7-methoxy-2,3-dihydro-1H-inden-1-amine may be used as a building block or intermediate in the synthesis of more complex organic compounds, particularly those with aromatic structures.
Used in Pharmaceutical Industry:
Given its unique structure, 7-methoxy-2,3-dihydro-1H-inden-1-amine could potentially be used as a starting material or intermediate in the development of new pharmaceutical compounds, including drugs with novel therapeutic properties.
Used in Research and Development:
As a relatively unexplored compound, 7-methoxy-2,3-dihydro-1H-inden-1-amine may be utilized in research and development settings to study its chemical properties, reactivity, and potential applications in various fields.

Upstream product

• 1187160-18-4 1-amino-7-methoxyindane hydrochloride 
• 928169-32-8 4-bromo-7-methoxy-2,3-dihydro-1H-inden-1-ol 
• 908108-58-7 7-methoxy-indan-1-one oxime 

Relevant articles and documents

Synthesis and carbonic anhydrase inhibitory effects of novel sulfamides derived from 1-aminoindanes and anilines

Three 1-aminoindanes, four anilines and BnOH or t-BuOH were reacted with chlorosulfonyl isocyanate to give sulfamoyl carbamates. Pd-C catalysed hydrogenolysis reactions of carbamates or deprotection of the Boc group of the carbamates with CF3CO2H afforded

6-SUBSTITUTED BENZOXAZINES

The present invention is concerned with 6-substituted benzoxazine derivatives of formula (I) wherein X, Y, R1 and R2 are as described herein, their manufacture, and pharmaceutical compositions containing them. The active compounds of the present invention are 5-HT5A receptor antagonists, useful in the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders, Parkinson's disease, psychiatric disorders or gastrointestinal disorders.

2-AMINOQUINOLINES

The present invention is concerned with 2-aminoquinoline derivatives of formula I where R1, R2, R3, R4, R5, R6, A, and n are as defined in the specification and claims, their use 5-HT5

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.